Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus
- PMID: 8640557
- DOI: 10.1038/nm0696-662
Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus
Abstract
Naturally pyrazinamide (PZA)-resistant Mycobacterium bovis and acquired PZA-resistant M. tuberculosis strains lose pyrazinamidase (PZase). To investigate the molecular mechanism of PZA resistance, we have cloned the gene (pncA) encoding M. tuberculosis PZase. Mutations in pncA were identified in both types of PZA-resistant strains, and transformation of these strains with a functional pncA gene restored PZase activity and PZA susceptibility. These findings, besides providing the basis for understanding how PZA works, should have implications for rapid detection of PZA-resistant clinical isolates of M. tuberculosis and also for rapid differentiation of M. bovis from M. tuberculosis strains.
Comment in
-
Pyrazinamide--on the antituberculosis drug frontline.Nat Med. 1996 Jun;2(6):635-6. doi: 10.1038/nm0696-635. Nat Med. 1996. PMID: 8640549 No abstract available.
Similar articles
-
Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide.Antimicrob Agents Chemother. 1999 Mar;43(3):537-42. doi: 10.1128/AAC.43.3.537. Antimicrob Agents Chemother. 1999. PMID: 10049264 Free PMC article.
-
Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis.Tuber Lung Dis. 1997;78(2):117-22. doi: 10.1016/s0962-8479(98)80004-x. Tuber Lung Dis. 1997. PMID: 9692180
-
Estimation of pyrazinamidase activity using a cell-free In vitro synthesis of pnca and its association with pyrazinamide susceptibility in Mycobacterium tuberculosis.Int J Mycobacteriol. 2018 Jan-Mar;7(1):16-25. doi: 10.4103/ijmy.ijmy_187_17. Int J Mycobacteriol. 2018. PMID: 29516881
-
The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.J Commun Dis. 2006 Mar;38(3):288-98. J Commun Dis. 2006. PMID: 17373362 Review.
-
The curious characteristics of pyrazinamide: a review.Int J Tuberc Lung Dis. 2003 Jan;7(1):6-21. Int J Tuberc Lung Dis. 2003. PMID: 12701830 Review.
Cited by
-
Challenges in the development of drugs for the treatment of tuberculosis.Braz J Infect Dis. 2013 Jan-Feb;17(1):74-81. doi: 10.1016/j.bjid.2012.10.009. Epub 2013 Jan 1. Braz J Infect Dis. 2013. PMID: 23287547 Free PMC article. Review.
-
Molecular dynamics simulations suggest ligand's binding to nicotinamidase/pyrazinamidase.PLoS One. 2012;7(6):e39546. doi: 10.1371/journal.pone.0039546. Epub 2012 Jun 26. PLoS One. 2012. PMID: 22761821 Free PMC article.
-
Synthesis and biological activity of alkynoic acids derivatives against mycobacteria.Chem Phys Lipids. 2016 Jan;194:125-38. doi: 10.1016/j.chemphyslip.2015.08.001. Epub 2015 Aug 6. Chem Phys Lipids. 2016. PMID: 26256431 Free PMC article.
-
Learning from the past for TB drug discovery in the future.Drug Discov Today. 2017 Mar;22(3):534-545. doi: 10.1016/j.drudis.2016.09.025. Epub 2016 Oct 4. Drug Discov Today. 2017. PMID: 27717850 Free PMC article. Review.
-
Novel genetic polymorphisms that further delineate the phylogeny of the Mycobacterium tuberculosis complex.J Bacteriol. 2006 Jun;188(12):4271-87. doi: 10.1128/JB.01783-05. J Bacteriol. 2006. PMID: 16740934 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical